Adaptimmune Ther ADR (ADAP)

$1.10 0.01 (0.92%)
16:00 EDT ADAP Stock Quote Delayed 30 Minutes

Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?

A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.09B
PE Ratio -6.47
EPS -0.17
Volume (Avg. Vol.) 562,736
Day's Range $1.06 - $1.12
52-Week Range $1.01 - $2.65
Dividend & Yield N/A (N/A)